Mobile Menu

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us
  • Menu
  • Skip to primary navigation
  • Skip to main content

https://eyecro.com

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us

Preclinical Ophthalmic Contract Research

Telemedicine Doubles Screening Rates for Retinopathy

October 24, 2012 //  by stanselb

 

The use of telemedicine helped a primary care clinic more than double the percentage of diabetic patients undergoing screening for retinopathy over the course of a year, according to a research letter published this month in the Archives of Internal Medicine.

The researchers, based out of the University of North Carolina at Chapel Hill, approached the study hypothesizing that telemedicine was “an emerging strategy” to boost retinopathy screenings for diabetic patients. The results backed up their initial predictions, as screening frequency jumped from 32 percent to 71 percent in one year’s time.

“Despite well-accepted national and international guidelines, on average, less than 50 percent of patients with diabetes mellitus undergo screening for retinopathy in the United States,” the authors wrote. “Introducing this technology at the point of care of the primary care physician could substantially reduce barriers and improve early detection of retinopathy.”

Read the entire article here.

Category: NewsTag: diabetes mellitus, Diabetic retinopathy, screening

Previous Post: « eyecro’s First Published Article in Molecular and Cellular Biology
Next Post: Rosemary Compound Shown To Help Fight Macular Degeneration In Mouse Model »

© 2023 · EyeCRO · All Rights Reserved.